Skip to main content

Table 2 Univaraite and multivariate analysis of DFS in cervical cancer patients

From: Variation of PD-L1 expression in locally advanced cervical cancer following neoadjuvant chemotherapy

 DFS (univariate analysis)DFS (multivariate analysis)
HR95%CIpHR95%CIp
Age (< 40/≥40)1.1580.473–2.8340.748   
Histo-grade (I-II/III)1.1460.468–2.8040.765   
Figo stage (Ib2/ IIa2)2.4561.199–5.0330.0142.3861.119–5.0890.024
Clinical response (CR/non-CR)0.4410.214–0.9090.0260.5310.239–1.1801.120
Lymph-node metastasis (yes/no)2.7021.104–6.6160.0301.2510.448–3.4970.669
PDL1 after NAC (High/Low)0.8930.624–1.2790.537   
PDL1 (increase or stable/decrease)0.2990.091–0.9870.0480.3700.108–1.2660.113
CD3 after NAC (High/Low)0.7440.361–1.5320.423   
CD4 after NAC (High/Low)0.8560.418–1.7550.672   
CD8 after NAC (High/Low)0.4710.221–1.0070.0520.4930.228–1.0650.072